🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of recombi...
Status
Unknown
Location
307 Hospital of PLA
Start Date
2015-05
Trial ID
NCT02455596
Treatments Being Tested
RATIONALE: STI571 may interfere with the growth of cancer cells and may be ...
Status
Completed
Location
Novartis Pharmaceuticals Corporation
Start Date
2000-06
Trial ID
NCT00006053
Treatments Being Tested
RATIONALE: Vaccines made from a patient's dendritic cells and tumor cells m...
Status
Completed
Location
Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center
Start Date
2003-12
Trial ID
NCT00085436
Treatments Being Tested
Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Status
Completed
Location
Alabama CRS
Start Date
2012-04
Trial ID
NCT01482767
Treatments Being Tested
The purpose of this study is to evaluate if a 12-week total regimen of tela...
Status
Terminated
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01459913
Treatments Being Tested
Current clinical practices has shown promising prospects of the therapy str...
Status
Completed
Location
Beijing Ditan Hospital, Capital Medical University
Start Date
2019-12-04
Trial ID
NCT04846491
RATIONALE: Interferon alfa may interfere with the growth of cancer cells. I...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2002-04
Trial ID
NCT00045422
Treatments Being Tested
This early phase IIA trial studies how well celecoxib, recombinant interfer...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2018-04-19
Trial ID
NCT03403634
Treatments Being Tested
Patients with chronic hepatitis genotype 1b, who are intolerant or ineligib...
Status
Completed
Location
Local Institution
Start Date
2014-02-28
Trial ID
NCT01995266
Treatments Being Tested
Comparison of methotrexate versus interferon-alfa 2b on efficacy, safety an...
Status
Terminated
Location
Centrum Onkologii im. prof. F. Łukaszczyka
Start Date
2014-06-01
Trial ID
NCT02323659
Treatments Being Tested